» Articles » PMID: 10495420

Two Distinct Regions of Deletion on Chromosome 13q in Primary Nasopharyngeal Carcinoma

Overview
Journal Int J Cancer
Specialty Oncology
Date 1999 Sep 25
PMID 10495420
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Nasopharyngeal carcinoma (NPC) is rare in most parts of the world, but prevalent in Southern China. Although this disease poses a serious health problem in our population, the genetic alterations that lead to the development of NPC have yet to be defined. In a comparative genomic hybridization (CGH) study on NPC by our group, loss of the long arm of chromosome 13 has been identified as a frequent event. To investigate further the involvement of this genetic alteration in NPC tumorigenesis, we examined 31 primary NPC tumours by LOH analysis with a panel of 13 microsatellite polymorphic markers distributed along the long arm of chromosome 13. It was found that 19/31 tumours (60%) showed LOH for markers on chromosome 13q. The highest frequency of LOH was found at loci D13S133 (53.6%) on 13q14.3 and D13S796 (38.5%) on 13q32-34. Two distinct smallest deletion regions were delineated: the first region between D13S133 and D13S119 at 13q14.3-22, and the second region between D13S317 and D13S285 at 13q31-34. Our findings show that LOH of 13q is a common event in NPC and that at least 2 putative tumour-suppressor loci may be present on 13q. Mapping of the critical regions of these loci suggests that some candidate tumour-suppressor genes on 13q, other than Rb and BRCA2, may be involved in the development of NPC.

Citing Articles

Diagnostic and Prognostic Indications of Nasopharyngeal Carcinoma.

E A R E, Irekeola A, Yean Yean C Diagnostics (Basel). 2020; 10(9).

PMID: 32825179 PMC: 7554987. DOI: 10.3390/diagnostics10090611.


Prognostic implications of a molecular classifier derived from whole-exome sequencing in nasopharyngeal carcinoma.

Wang H, Li F, Liu N, Liu X, Yang X, Guo Y Cancer Med. 2019; 8(6):2705-2716.

PMID: 30950204 PMC: 6558473. DOI: 10.1002/cam4.2146.


Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.

Chiu S, Wu C, Fang C, Yu S, Hsu H, Chow Y Oncotarget. 2014; 5(18):8583-601.

PMID: 25261366 PMC: 4226706. DOI: 10.18632/oncotarget.2323.


Restoration of miR17/20a in solid tumor cells enhances the natural killer cell antitumor activity by targeting Mekk2.

Jiang H, Wang P, Li X, Wang Q, Deng Z, Zhuang X Cancer Immunol Res. 2014; 2(8):789-99.

PMID: 24801835 PMC: 4396632. DOI: 10.1158/2326-6066.CIR-13-0162.


Investigation of the miR16-1 (C > T) + 7 Substitution in Seven Different Types of Cancer from Three Ethnic Groups.

Yazici H, Zipprich J, Peng T, Akisik E, Tigli H, Isin M J Oncol. 2009; 2009:827532.

PMID: 19865490 PMC: 2766826. DOI: 10.1155/2009/827532.